Lianhua Technology has announced the signing of a long-term agreement with its customers for its K-amine product, implementing a cost-plus pricing strategy to uphold consistent gross margins. In response to recent media reports concerning chlorantraniliprole, the company has clarified that it has not received any notification of an uptick in customer demand, and any associated impacts on the company remain minimal. Lianhua Technology urges investors to approach market speculations with a discerning eye and refrain from indiscriminate trend-following.